Clave

Genbioma is a company focused on developing oral probiotic supplements and medicines aimed at improving glycemic regulation, particularly for individuals with prediabetes. By leveraging the crucial role of probiotics and gut microbiota, Genbioma's research and development efforts center on creating products that promote long-term health benefits. The company seeks to harness the potential of bioactive compounds to support patients in managing their blood sugar levels effectively. Through its evidence-based approach, Genbioma aims to contribute to the understanding and treatment of glycemic control in early stages of diabetes.

Corify Care SL is a medical technology company based in Madrid, Spain, focused on improving the treatment of atrial fibrillation through its innovative non-invasive electrocardiographic imaging device, ACORYS. This device allows healthcare professionals to visualize the electrical activity of the heart in real time without the need for invasive procedures, such as catheters or complex imaging techniques like MRI or CT scans. By addressing the limitations of existing solutions, ACORYS enhances the clinical management of cardiac arrhythmias, enabling accurate mapping and identification of optimal treatment strategies for patients. The technology has the potential to benefit over 10 million atrial fibrillation patients in Europe alone. Established in 2019, Corify Care is backed by leading experts in cardiac arrhythmias, positioning it as a promising player in the medical device sector.

Homedoctor is an online medical care platform that provides users with access to video consultations with healthcare specialists across various fields, including pediatrics, gynecology, internal medicine, dermatology, psychiatry, and nutrition. The platform features a health robot that enables users to monitor their vital signs and document the data in their medical records, helping to identify potential health issues. By facilitating live video consultations, Homedoctor ensures that patients receive accurate diagnoses and appropriate medical advice from qualified professionals. This innovative approach to healthcare delivery aims to enhance accessibility and efficiency in medical consultations, catering to a diverse range of health concerns.

Sincrolab is a company focused on creating and commercializing technological solutions for neuropsychological rehabilitation, particularly for patients with neurodevelopmental disorders. It has developed an artificial intelligence-driven digital prescription platform that utilizes video games delivered via mobile devices to facilitate cognitive recovery and skill development. The platform is designed to provide personalized, standardized, and scientifically validated cognitive stimulation training, enabling health professionals to create tailored rehabilitation plans. Through its innovative approach, Sincrolab aims to enhance the management of cognitive rehabilitation for individuals facing neurodevelopmental challenges.

inBiot Monitoring offers real-time monitoring of indoor air quality in buildings.

MainRail is an IT solutions company focused on enhancing infrastructure maintenance operations, particularly within the rail industry. They offer a customizable IT platform designed to manage all maintenance-related activities efficiently. Additionally, MainRail provides a suite of Internet of Things (IoT) devices that facilitate continuous and cost-effective inspections of infrastructure. Their services encompass various specialties, including railway dynamics, information and communication systems, system dynamics, electromagnetic compatibility analysis, and reliability, availability, maintainability, and safety (RAMS) analysis. By leveraging these technologies, MainRail aims to help clients reduce costs while improving the quality and capacity of their network.

Shakers operates a digital platform designed to enhance collaboration between freelancers and companies. By leveraging advanced technology, the platform connects organizations with verified talent, focusing on aligning personal and professional attributes such as experience, skills, motivations, and personality. HR leaders can utilize Shakers' AI-powered smart team builder to create new teams or augment existing ones, streamlining the process of team formation. Additionally, the platform offers tools for communication, task organization, project management, and performance feedback, allowing users to manage their projects efficiently and effectively.

D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.

Fisify is a pioneering digital physiotherapy platform that enhances the quality of treatment and recovery rates for health insurance companies, hospitals, and physiotherapy centers. Utilizing artificial intelligence, Fisify offers a virtual physiotherapist that monitors patients in real time, guiding them from the moment of injury through to full recovery. The platform provides personalized exercise programs, which are monitored via camera technology, ensuring that patients receive effective support tailored to their individual needs. This innovative approach aims to streamline the injury recovery process and improve overall health outcomes.

Done Properly Company SpA is a food technology company based in Santiago, Chile, founded in 2017. It specializes in manufacturing vitamins and nutritional supplements, including probiotic drinks, protein powders, and food ingredients aimed at enhancing gastrointestinal health. The company focuses on developing innovative ingredients through fermentation technologies, catering to the food industry’s need for healthier and more sustainable products. By collaborating with consumer packaged goods companies and major global food corporations, Done Properly enables these partners to reformulate their offerings in line with emerging consumer trends for healthier and environmentally friendly options, all while maintaining the existing consumer experience.

Neuraptic AI is a developer of artificial intelligence technology aimed at enhancing human lives through advancements in machine learning. The company offers a subscription-based machine learning operations platform that enables clients to design, train, and maintain their AI systems effortlessly by uploading data. This user-friendly approach allows businesses to implement AI solutions that transform their data into profitable assets, streamlining processes and improving decision-making. Neuraptic AI focuses on making advanced AI accessible to a wide range of users, thereby facilitating the integration of machine learning into various applications and industries.

Cuyna operates a virtual kitchens network designed to help restaurant brands expand their reach through delivery-only locations. By minimizing expansion risks associated with capital expenditures, operational costs, and cost of goods sold, Cuyna facilitates the launch of new locations with a reduced time-to-market. The company connects premier restaurant brands to its kitchen network, managing the sourcing of ingredients and products, processing orders, and preparing meals while maintaining high quality. Additionally, Cuyna collaborates with top shipping companies and delivery platforms to ensure efficient delivery, enabling restaurants to enhance their performance and achieve revenue growth through consistent quality and service.

InsektLabel Biotech develops versatile ingredients with reduced environmental impact for different segments within human and/or functional food. It product of the process itself to improve soil health and plant nutrition.

BQC Redox Technologies is a biotechnology company focused on developing and designing devices to measure redox parameters. The company offers kits and electrochemical devices that evaluate the levels of oxidation and antioxidants in various products. These tools are accessible through mobile applications, enabling businesses in the biomedical and cosmetics sectors to assess key variables such as total antioxidant capacity, enzymatic activity, molecular damage, and the presence of phenolic compounds and reactive oxygen species. BQC Redox Technologies aims to support companies in making informed decisions regarding product quality and efficacy through precise measurements.

Ecomagnet specializes in the production of magnets tailored for electric motors, generators, hard drives, and speakers, as well as providing magnetic solutions for various industrial sectors, including electromobility, wind power, automation, naval, and home appliances. The company has developed innovative manufacturing technology that converts discarded magnets into recycled anisotropic NdFeB magnet powder, which is then combined with an epoxy resin to create a bonded powder. This approach not only enhances the sustainability of magnet production but also allows clients to utilize recycled materials, thereby contributing to the conservation of natural resources and promoting an eco-friendly business model.

Abanza Tecnomed SL is a Spanish company based in Mutilva Alta that specializes in the research and development of medical instruments and devices, particularly in the field of sports medicine. Founded in 2014, the company focuses on creating advanced surgical instruments for knee ligament reconstruction. Abanza Tecnomed emphasizes biomedical innovation and is supported by a multidisciplinary R&D team and a top-tier medical advisory board, ensuring the precision and safety of its products. The company is dedicated to producing cutting-edge devices that enhance the efficiency and effectiveness of medical professionals in their practices.

Nemis Technologies AG is a Swiss biotech startup founded in 2018 and headquartered in Dübendorf, Switzerland. The company specializes in the innovation and development of diagnostic test kits utilizing AquaSpark technology, which allows for on-site pathogen detection. Its diagnostic kits, which include bacteria-specific reagents and swabs, are designed for microbiological detection across various sectors, including food safety, clinical diagnostics, and water treatment. By addressing the challenges of ensuring safe food and environmental monitoring, Nemis Technologies aims to set new benchmarks for microbiological excellence and improve safety programs at cost-efficient prices.

Berba operates a crowdsourced translation marketplace that aims to enhance communication across cultures through a blend of human expertise and artificial intelligence. Founded from a passion for languages and technology, the company focuses on delivering high-quality translations efficiently. By managing translators across 16 time zones and employing live tracking of documents, Berba ensures rapid turnaround times while maintaining the authenticity and naturalness of translations. Their approach leverages the strengths of both human translators and advanced AI technology, facilitating a seamless translation process that meets the evolving demands of global communication.

Deep Detection specializes in the development of multispectral X-ray cameras aimed at enhancing inspection processes in high-speed manufacturing environments. The company's technology leverages deep learning alongside photonics and micro-electronics to differentiate between various material types and analyze their physical and chemical characteristics. This capability allows for the identification and characterization of attributes such as composition and quality in a wide range of products, including food items and lightweight materials. By enabling continuous inspection on production lines, Deep Detection helps businesses maintain product standards and safety, ensuring the integrity of their brands. Their innovative solutions are applicable to diverse sectors, addressing needs such as food quality assessment and the inspection of both homogeneous and non-homogeneous substrates.

Ecomagnet specializes in the production of magnets tailored for electric motors, generators, hard drives, and speakers, as well as providing magnetic solutions for various industrial sectors, including electromobility, wind power, automation, naval, and home appliances. The company has developed innovative manufacturing technology that converts discarded magnets into recycled anisotropic NdFeB magnet powder, which is then combined with an epoxy resin to create a bonded powder. This approach not only enhances the sustainability of magnet production but also allows clients to utilize recycled materials, thereby contributing to the conservation of natural resources and promoting an eco-friendly business model.

MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.

MainRail is an IT solutions company focused on enhancing infrastructure maintenance operations, particularly within the rail industry. They offer a customizable IT platform designed to manage all maintenance-related activities efficiently. Additionally, MainRail provides a suite of Internet of Things (IoT) devices that facilitate continuous and cost-effective inspections of infrastructure. Their services encompass various specialties, including railway dynamics, information and communication systems, system dynamics, electromagnetic compatibility analysis, and reliability, availability, maintainability, and safety (RAMS) analysis. By leveraging these technologies, MainRail aims to help clients reduce costs while improving the quality and capacity of their network.

Corify Care SL is a medical technology company based in Madrid, Spain, focused on improving the treatment of atrial fibrillation through its innovative non-invasive electrocardiographic imaging device, ACORYS. This device allows healthcare professionals to visualize the electrical activity of the heart in real time without the need for invasive procedures, such as catheters or complex imaging techniques like MRI or CT scans. By addressing the limitations of existing solutions, ACORYS enhances the clinical management of cardiac arrhythmias, enabling accurate mapping and identification of optimal treatment strategies for patients. The technology has the potential to benefit over 10 million atrial fibrillation patients in Europe alone. Established in 2019, Corify Care is backed by leading experts in cardiac arrhythmias, positioning it as a promising player in the medical device sector.

Shakers operates a digital platform designed to enhance collaboration between freelancers and companies. By leveraging advanced technology, the platform connects organizations with verified talent, focusing on aligning personal and professional attributes such as experience, skills, motivations, and personality. HR leaders can utilize Shakers' AI-powered smart team builder to create new teams or augment existing ones, streamlining the process of team formation. Additionally, the platform offers tools for communication, task organization, project management, and performance feedback, allowing users to manage their projects efficiently and effectively.

Uptech Sensing is an engineering corporation with in-house solutions for providing, installing, and commissioning fiber optic monitoring solutions. The company produces optical fiber-based monitoring equipment for distributed measurement, also known as linear measurement, of parameters like temperature, deformation, and acoustics.

AgroSingularity is a foodtech and environmental impact company that produces plant-based products for the food and biotechnology industries. AgroSingularity enhances flavor, color, micronutrients, and other functionalities with natural and sustainable ingredients. AgroSingularity's ingredients are made from non-value-added products and by-products of plant origin, resulting in food production that is sustainable.

Genbioma is a company focused on developing oral probiotic supplements and medicines aimed at improving glycemic regulation, particularly for individuals with prediabetes. By leveraging the crucial role of probiotics and gut microbiota, Genbioma's research and development efforts center on creating products that promote long-term health benefits. The company seeks to harness the potential of bioactive compounds to support patients in managing their blood sugar levels effectively. Through its evidence-based approach, Genbioma aims to contribute to the understanding and treatment of glycemic control in early stages of diabetes.

RAAAM Memory Technologies Ltd. specializes in innovative on-chip memory solutions designed for the semiconductor industry. The company has developed a high-density memory technology that significantly enhances memory capacity, providing up to 50% greater density compared to traditional options without incurring additional costs, complexity, or performance drawbacks. RAAAM's technology serves as a drop-in replacement for static random access memory (SRAM) in system on chips (SoCs), allowing semiconductor companies to achieve area and power reductions while utilizing standard CMOS manufacturing processes. This advancement enables clients to maximize on-chip memory capacity within a smaller silicon die size, streamlining production and improving efficiency.

Polimerbio specializes in the design and development of sanitary products utilizing biocompatible and biodegradable polymers. The company focuses on creating polymer-based medical devices aimed at replacing non-biodegradable alternatives and enhancing soft tissue regeneration. By employing innovative materials for biomedical applications and tissue engineering, Polimerbio enables medical professionals to minimize surgical interventions and associated hospital costs while improving the quality of life for patients. The company oversees all stages of product development, from fundamental research to market introduction, adhering to a quality management system and necessary regulatory standards.

Genbioma is a company focused on developing oral probiotic supplements and medicines aimed at improving glycemic regulation, particularly for individuals with prediabetes. By leveraging the crucial role of probiotics and gut microbiota, Genbioma's research and development efforts center on creating products that promote long-term health benefits. The company seeks to harness the potential of bioactive compounds to support patients in managing their blood sugar levels effectively. Through its evidence-based approach, Genbioma aims to contribute to the understanding and treatment of glycemic control in early stages of diabetes.